Réf. : BL-RE-127853Réf. fabricant : 18406818 10 mL
1 826,00 € HT
CaptureSelect C5 Affinity Matrix has been specifically designed for the depletion or purification of human complement component 5 from human plasma.
Débit
50 to 200 cm/hr. (Up to 2 bar)
Matrice
Agarose-based
Contenu et stockage
Store in refrigerator (2°C to 8°C).
Conditions d’expédition
Wet Ice
Granulométrie
65 ± 10 μm
Marque
Thermo Scientific
Features of this affinity matrix include:
The high selectivity and yields obtained using CaptureSelect C5 Affinity Matrix enables a robust and efficient purification process with excellent purity obtained in one step.
Points forts
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics
Matrix: agarose-based
Average particle size: 65 ± 10 μm
Ligand: CaptureSelect C5 affinity ligand
Ligand coupling method: epoxide
Flow characteristics: 50–200 cm/h (up to 2 bar)
Formulation buffer: 20% (v/v) ethanol
Caractéristiques principales
Highly selective for human complement component 5
Complex growth media with fetal calf serum can be applied
Non-animal derived
Caractéristiques techniques
Marque
Thermo Scientific
Réf. B-LABO
BL-RE-127853
Réf. fabricant
18406818
Débit
50 to 200 cm/hr. (Up to 2 bar)
Matrice
Agarose-based
Contenu et stockage
Store in refrigerator (2°C to 8°C).
Conditions d’expédition
Wet Ice
Granulométrie
65 ± 10 μm
Forme
Agarose Bead
Gamme de produits
CaptureSelect™
Quantité
10 mL
Type
Affinity Matrix
Type de ligand
C5 affinity ligand
Phase stationnaire
C5
Une question, une configuration particulière ? Contactez-nous pour un devis.
